CXCR3 and neoplasm: Results from our in vivo studies thus far have shown that GSK126 in combination with anti-PD-1, promotes the infiltration of activated T cells within the tumor perhaps trafficking from the draining lymph nodes where there is evidence of accumulation of CXCR3+ T cells.